This is a substantial study based on interviews with 150 pharmaceutical and biotechnology company representatives. Respondents graded 25 small, mid-size and large CROs across 20 important capabilities that affect provider selection and delivery quality. The report contains 320 pages, including over 300 charts and graphs, and in-depth analysis not previously available to the industry.
This study - designed, executed and analyzed by research professionals from the drug development industry - is a 'Consumer Reports'-style guide to buying and delivering quality product development services.
Service buyers can rely on this report to substantially inform their selection of development partners that best fit their unique needs.
Service providers can rely on this report to provide them with clear service enhancement recommendations and opportunities to differentiate themselves from the crowded, competitive market of CROs.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
